Hypoxic/ischemic brain injury in the neonate can activate an inflammatory cascade, which potentiates cellular injury. The role of microglia in this inflammatory response has not been studied extensively. We used an in vitro model of murine microglia to investigate changes in microglial cytokine release and injury during early development. Isolated microglia were subjected to lipopolysaccharide (LPS) activation or injury by glucose deprivation (GD), serum deprivation (SD), or combined oxygenglucose deprivation (OGD) for varying durations. The extent and the type of cell death were determined by trypan blue, terminal deoxynucleotidyl end-nick labeling, and annexin staining. Earlyculture microglia (2-3 d in purified culture) showed significantly more apoptotic cell death after SD, GD, and OGD compared with microglia maintained in culture for 14 -17 d. Measurements of tumor necrosis factor-␣ (TNF-␣) and IL-1 in culture media demonstrated that OGD induced greater release of both TNF-␣ and IL-1 than LPS activation, with early-culture microglia producing more TNF-␣ compared with late-culture microglia.Microglia that are cultured for a short time are more sensitive to ischemia-like injury in vitro than those that are cultured for longer durations and may contribute to worsening brain injury by increased release of inflammatory cytokines. Inhibition of microglial activation and decreasing proinflammatory cytokine release may be targets for reduction of neonatal hypoxic/ischemic brain injury. Neonatal hypoxic/ischemic brain injury causes significant long-term neurologic morbidity in survivors. Deleterious outcomes include cerebral palsy, mental retardation, and cognitive and behavioral dysfunction. Hypoxia and ischemia can occur with birth asphyxia or prenatally with chronic placental vascular insufficiency and fluctuations in cerebral blood flow. Another factor that contributes to brain injury is infection and inflammation. Maternal chorioamnionitis, whether acute or subclinical, has been associated with a 9-fold increased risk for cerebral palsy (1).Recently, the contribution of inflammation to hypoxic/ ischemic brain injury has been recognized. Microglia, or resident brain macrophages, are the major inflammatory cell type in the CNS. Upon activation, they release proinflammatory cytokines, oxygen free radicals, and nitric oxide and can stimulate astrocytes to do the same (2,3). The release of cytokines from activated microglia may further exacerbate neuronal injury, whereas inhibition of tumor necrosis factor-␣ (TNF-␣) reduces neuronal death in vitro and in vivo (4,5). The potentiation of hypoxic/ischemic injury by inflammation is a significant therapeutic target in adult cerebral ischemia (6,7) that has not been studied extensively in the perinatal setting.Sensitivity to hypoxic/ischemic injury is known to change with development. Data from the National Collaborative Perinatal Project showed that periventricular leukomalacia peaked